跳至主要内容
临床试验/NCT02319291
NCT02319291已完成不适用

Outcomes of Total Knee Arthroplasty (TKA) Using the Sigma PS150 Primary Total Knee System

DePuy Orthopaedics4 个研究点 分布在 2 个国家目标入组 175 人开始时间: 2015年2月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
175
试验地点
4
主要终点
Implant Survivorship

研究概览

简要总结

This registry is intended to evaluate the clinical outcomes of the DePuy P.F.C. Sigma PS150 RP Total Knee System. 200 participants will be enrolled prospectively or retrospectively and the follow up period will be 5 years. Data collection will include Radiographic Analysis, Knee Society Evaluation and Adverse Events.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Other

入排标准

性别
All
接受健康志愿者

入选标准

  • Primary total knee replacement for any indication in accordance with the Instructions For Use accompanying the SIGMA PS150 implant.
  • Signed Informed Patient Consent

排除标准

  • There are no exclusion criteria for this registry.

结局指标

主要结局

Implant Survivorship

时间窗: 5 years

Lack of revision with revision meaning no removal or replacement of any TKA component.

次要结局

  • Flexion(1, 3 & 5 years)
  • Knee Society Score - Function(1, 3 & 5 years)
  • Knee Society Score - Knee Score(1, 3 & 5 years)
  • Extension(1, 3 & 5 years)
  • Adverse Events(1, 3 & 5 years)
  • Pain sub-question of the Knee Society Score(1, 3 & 5 years)
  • Radiographic Analysis(1, 3 & 5 years)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (4)

Loading locations...

相似试验